© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 11, 864-865,
June 7, 2000
© 2000 Oxford University Press
NEWS |
Almost Serendipity: Alcoholism Drug Reverses Drug Resistance In Vitro
Sometimes in science, luck and an open mind count as much as diligence and dedication. Just ask David Clarke, Ph.D., and Tip Loo, M.D., Ph.D., protein structure researchers at the University of Toronto.
|
Their story starts with a spicy meal, includes a fortuitous encounter with a mislabeled drug, and ends with a discovery that could open an unexpected research agenda. In this issue of the Journal (p. 898), Clarke and Loo report that disulfiram (AntabuseTM), an inexpensive anti-alcoholism drug, blocks cancer drug resistance in cell cultures.
While still preclinical, the Toronto work presents an entirely new route for overcoming one of cancer therapys major stumbling blocks. Drug resistance stymies treatment in half or more of all cancer patients. Tumors often shrink during initial chemotherapy, only to regrow more resistant to
Its in the Fold
Curried Brainstorm
